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Abstract
Introduction—Actinomyces naeslundii has been recovered from traumatized permanent teeth 
diagnosed with necrotic pulps. In this work, a triple antibiotic paste (TAP)–mimic scaffold is 
proposed as a drug-delivery strategy to eliminate A. naeslundii dentin biofilm.
Methods—Metronidazole, ciprofloxacin, and minocycline were added to a polydioxanone (PDS) 
polymer solution and spun into fibrous scaffolds. Fiber morphology, mechanical properties, and 
drug release were investigated by using scanning electron microscopy, microtensile testing, and 
high-performance liquid chromatography, respectively. Human dentin specimens (4 × 4 × 1 mm3, 
n = 4/group) were inoculated with A. naeslundii (ATCC 43146) for 7 days for biofilm formation. 
The infected dentin specimens were exposed to TAP-mimic scaffolds, TAP solution (positive 
control), and pure PDS (drug-free scaffold). Dentin infected (7-day biofilm) specimens were used 
for comparison (negative control). Confocal laser scanning microscopy was done to determine 
bacterial viability.
Results—Scaffolds displayed a submicron mean fiber diameter (PDS = 689 ± 312 nm and TAP-
mimic = 718 ± 125 nm). Overall, TAP-mimic scaffolds showed significantly (P ≤ .040) lower 
mechanical properties than PDS. Within the first 24 hours, a burst release for all drugs was seen. 
A sustained maintenance of metronidazole and ciprofloxacin was observed over 4 weeks, but not 
for minocycline. Confocal laser scanning microscopy demonstrated complete elimination of all 
viable bacteria exposed to the TAP solution. Meanwhile, TAP-mimic scaffolds led to a significant 
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(P < .05) reduction in the percentage of viable bacteria compared with the negative control and 
PDS.
Conclusions—Our findings suggest that TAP-mimic scaffolds hold significant potential in the 
eradication/elimination of bacterial biofilm, a critical step in regenerative endodontics.
Keywords
Antibiotic; bacteria; disinfection; electrospinning; nanofibers; pulp; regeneration; root canal; 
scaffold; stem cells
Regeneration of the pulp-dentin complex is highly dependent on the effective elimination of 
bacterial overgrowth within the root canal system (1, 2). Several microbial species have 
been identified inside root canals, including but not limited to Actinomyces naeslundii. A 
gram-positive filamentous, rod-shaped facultative anaerobe commonly found in the 
gastrointestinal tract (3), A. naeslundii has been increasingly correlated to the ability of 
biofilm formation and to failed endodontic therapy (4–6). Recently, A. naeslundii was 
detected in initial samples recovered from 10 of 15 traumatized permanent immature teeth 
diagnosed with necrotic pulps (7), suggesting the species may be relevant to regenerative 
endodontics.
The traditionally advocated substances used in endodontics to combat root canal infection, 
including sodium hypochlorite and calcium hydroxide, have shown ineffectiveness, mainly 
in cases of biofilm-related persistent infections (8, 9). In recent years, antibiotic mixtures 
such as triple antibiotic paste (TAP), a mixture of metronidazole (MET), ciprofloxacin 
(CIP), and minocycline (MINO) (10, 11), has gained increased evidence because of its 
clinically proven disinfection role within the revascularization strategy (12, 13). Regardless 
of the promising clinical evidence of pulp-like tissue regeneration, TAP uses a considerably 
high concentration (1 g/mL) of these antibiotics, which has demonstrated harmful effects on 
cell viability/proliferation (14, 15).
In light of this, the use of antibiotic-containing scaffolds as drug-delivery systems has 
demonstrated significant clinical potential (2, 16) when compared with TAP from a 
cytocompatibility standpoint. To our knowledge, no attempt has been made to develop and 
establish an A. naeslundii biofilm on dentin and understand its susceptibility to antimicrobial 
substances used in regenerative endodontics. We report for the first time the antimicrobial 
effects of a novel TAP-mimic scaffold on A. naeslundii–infected human dentin biofilm by 
using confocal laser scanning microscopy (CLSM).
Materials and Method
Synthesis of TAP-mimic Electrospun Polymer Scaffolds
Polydioxanone (PDS II; Ethicon, Somerville, NJ) filaments were subjected to an undying 
process to remove the violet color. In brief, PDS filaments were immersed in 
dichloromethane (Sigma-Aldrich, St Louis, MO) for 2 days (16–19). A 10 wt% PDS 
solution was prepared in 1,1,1,3,3,3-hexafluoro-2-propanol (Sigma-Aldrich). MET, CIP, and 
MINO (Sigma-Aldrich) were added to the polymer solution at 25 wt% concentration 
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(relative to the total PDS [600 mg] weight, ie, 150 mg of each drug) and mixed together 
under stirring (16–19). Pure PDS (control) and the TAP-mimic polymer solutions were spun 
into scaffolds (ie, flow rate 2 mL/h, 18-cm distance, and electrical voltage between 15 and 
19 kV). The polymer solutions were individually placed into plastic syringes (Becton, 
Dickinson and Company, Franklin Lakes, NJ) fitted with a metallic 27-gauge blunt needle, 
and the fibers were collected on an aluminum foil covered rotating mandrel at room 
temperature (RT) (16–19). To ensure complete elimination of any residual solvent, the 
scaffolds were dried for 48 hours under vacuum at RT and then stored at 4°C (16–19).
Fiber Morphology, Mechanical Characterization, and Drug Release
Fiber morphology of the scaffolds was investigated under a scanning electron microscope 
(FE-SEM, Model JSM-6701F; JEOL, Tokyo, Japan). The fiber diameter was measured 
(Image-J; National Institutes of Health, Bethesda, MD). The scaffolds' mechanical properties 
were determined by tensile testing (expert 5601; ADMET, Norwood, MA) of specimens (15 
× 3 mm2, n = 10/group/condition) under dry and wet conditions (24-hour incubation in 
phosphate-buffered saline [PBS]) (16,17).
Evaluation of the drug release from TAP-mimic scaffolds (15 × 15 mm2, n = 4) was done 
via high-performance liquid chromatography (HPLC). The scaffolds were weighed and then 
immersed in PBS (10 mL) for 28 days. Aliquots (1 mL) were removed from each solution at 
selected time points (1, 3, 7, 14, and 28 days) and replaced with an equal amount of fresh 
PBS at each collection (16, 18). Aliquots (10 μL) were analyzed by using HPLC-UV 
equipment (Agilent 1100 System, Palo Alto, CA; Zorbax SB-phenyl chromatography 
column), which consisted of a binary mobile phase of solvent systems A (0.1% formic acid 
in ddH2O, v/v) and B (0.1% formic acid in acetonitrile, v/v) in a gradient elution. Test 
parameters were described in detail elsewhere (16, 18). The percentage of the released drugs 
was then calculated on the basis of the initial weight of the scaffolds (16, 18).
Antimicrobial Evaluation of A. naeslundii Biofilm-infected Dentin Specimens
Caries-free human mandibular canines were collected under an approved (protocol 
#1407656657) local Institutional Review Board protocol (Indiana University). Teeth were 
washed, and the soft tissue remains were removed before storage in thymol 0.1%. After 
crown sectioning by using a diamond disk, the teeth were sectioned along the buccolingual 
plane, obtaining 2 halves for dentin specimen (4 × 4 × 1 mm3) preparation. The cementum 
was removed, and the specimens were wet-finished with SiC papers (600–1200 grit). All the 
specimens were immersed in 2.5% NaOCl and 17% EDTA (Inter-Med, Inc, Racine, WI) for 
3 minutes each in an ultrasonic bath (L&R 2014 Ultrasonic Cleaning System; L&R 
Manufacturing Company, Keamy, NJ) to remove the smear layer (19). Last, the specimens 
were rinsed in saline solution for 10 minutes, sterilized in an autoclave (121°C for 20 
minutes), and then randomly placed with the dentin side positioned upward in 24-well plates 
(Costar; Corning Life Sciences, Tewksbury, MA) before A naeslundii (ATCC 43146) 
inoculation. In brief, 200 μL of 16- to 18-hour culture of the bacterial suspension (ca. 106 
bacteria) was pipetted into each well containing 1.8 mL brain-heart infusion medium (Difco 
Laboratories Inc, Detroit, MI). The plates were kept (37°C) aerobically in an incubator for 7 
days to allow biofilm formation. The broth was changed every other day. All the specimens 
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were rinsed for 1 minute (2×) with PBS (Sigma-Aldrich) to remove nonadherent bacterial 
cells before treatment. Infected dentin specimens (n = 6/group) were randomly allocated to 3 
experimental groups: pure PDS scaffolds (drug-free), TAP-mimic scaffolds (13.15 ± 0.3 mg, 
ca. 3.3 mg of each antibiotic), TAP solution (50 mg/mL of each of the drugs), and the 
negative control group (7-day biofilm untreated). The scaffolds (15 × 15 mm2) were 
sterilized by ultraviolet irradiation (16–19) adapted to plastic inserts (CellCrown; Scaffdex 
Ltd, Tampere, Finland) and then placed into the wells containing the infected dentin 
specimens and 1 mL PBS (19). The plates were incubated under aerobic conditions at 37°C 
for 3 days, and the specimens were prepared for CLSM. Finally, the dentin specimens were 
rinsed in PBS (2×) to remove unbound bacteria and medium. Two specimens per group were 
prepared for scanning electron microscopy (SEM) imaging. The remaining specimens in 
each group were stained with the fluorescent LIVE/DEAD BacLight Bacterial Viability Kit 
L-7012 (Molecular Probes, Eugene, OR) containing SYTO 9 and propidium iodide (PI). The 
dyes were mixed in a 1:1 solution and applied to the specimens for 30 minutes at RT before 
CLSM analysis. Live bacteria presenting intact cell membranes were dyed green (SYTO 9), 
whereas dead bacteria with damaged membranes were stained red (PI) (20–23). A total of 16 
dentin specimens (n = 4/group) and 5 randomly selected microscopic fields were scanned, 
starting from the edges of the specimen to obtain 20 measurements per group. Images were 
acquired with a confocal/2-photon Leica TCS SP8 system (Leica Microsystems Inc, Buffalo 
Grove, IL) by using Leica HC PL APO 40 ×/1.3 oil immersion objective. Series of sections 
through the depth of tissue (Z-stacks) were collected by using optimal step size settings 
(0.35 μm); images were composed of 512 × 512 pixels (221 × 221 μm2). Data quantification 
and 3-dimensional volume reconstruction were performed by using dedicated software 
(Imaris 7.7; Bitplane USA, South Windsor, CT) (23, 24). Volume images were processed to 
extract a statistical parameter of live and dead bacteria volume. Data were presented as a 
ratio of LIVE/DEAD bacteria.
Statistical Analysis
The mechanical data were analyzed (SigmaPlot version 12; Systat Software Inc, San Jose, 
CA) by using two-way analysis of variance and Tukey test for multiple comparison (α = 
0.05). For CLSM analysis, groups were compared for differences in the percentage of dead 
bacterial cells by using the mixed-model analysis of variance, with a fixed effect for group 
and a random effect for sample, to account for measurements at multiple areas on each 
specimen. A variance stabilizing transformation (sin−1 [(percent dead)½) was used to satisfy 
the assumptions.
Results
Fiber Morphology, Mechanical Characterization, and Drug Release
A submicron mean fiber diameter was seen for both pure PDS (689 ± 312 nm) and TAP-
mimic (718 ± 125 nm) scaffolds (Fig. 1A and B). Whereas PDS scaffolds exhibited a wider 
fiber diameter distribution (Fig. 1C), the TAP-mimic scaffold presented a gaussian 
distribution (Fig. 1D), with most of the fibers ranging from 600 to 800 nm. Mechanical 
performances of the bioactive scaffolds are displayed in Figure 1E–G. Data analysis 
revealed that the scaffold (P = .020) and storage condition factors (P ≤ .001) were both 
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significant, although their interaction was not (P = .541). Figure 2 reveals a burst release of 
the drugs within the first 24 hours, which was sustained for MET and CIP but not for MINO, 
which displayed a progressive concentration reduction within 7 days of incubation.
Antimicrobial Evaluation of A. naeslundii Biofilm-infected Dentin Specimens
As shown in Table 1, all groups tested were statistically different from each other. TAP 
solution had the highest percentage of dead bacteria (P = .0022 versus TAP-mimic scaffold 
and P < .0001 versus pure PDS and control), followed by the TAP-mimic scaffold (P < .
0001 versus PDS scaffold and control), which was higher than the control (P = .0082). 
Figure 3A and B clearly show the presence of A. naeslundii biofilm inside the dentinal 
tubules (green) after 7 days (control group). The formulated TAP solution was able to 
eliminate all viable bacteria (Table 1 and Fig. 3D). Whereas for the PDS and control groups 
the CLSM findings (Fig. 3A and B) agreed with the SEM images (Fig. 3E and F) in terms of 
biofilm formation, the TAP-mimic scaffold was able to kill most of the bacteria (Fig. 3C), 
although without removing them from the surface (Fig. 3G). By contrast, TAP solution 
revealed the formation of insoluble agglomerates over the dentin surface (Fig. 3D and H). 
Figure 3 also displays macrophotographs in which both TAP-mimic scaffolds and the TAP 
solution led to a gray-brownish dentin discoloration, which was significantly more 
accentuated after TAP-solution exposure (Fig. 3L). Dentin discoloration was not observed in 
pure PDS or the negative control (7-day biofilm) (Fig. 3I and J).
Discussion
Besides antimicrobial properties, an ideal scaffold to be translated into the clinics for 
regenerative endodontics must present adequate mechanical properties, geometry, and 
clinical handleability. One of the key concerns toward the use of scaffolds in endodontics 
relates to the achievement of an intimate contact within the root canals, avoiding its 
displacement through the apical foramen and, consequently, the arrest of stem cell 
proliferation (2). This study investigated some important mechanical properties of a novel 
TAP-mimic PDS-based scaffold. Our data suggest that the addition of antibiotics led to a 
significant decrease in tensile strength, mainly after hydration (Fig. 1E). Antibiotics are 
usually more hydrophilic than most polymers (eg, polyesters) used to produce electrospun 
fibers (24–26), which, in turn, may have contributed to the significant decrease in physical 
stability of the TAP-mimic scaffold (26). Although the antibiotics' hydrophilic nature may 
have contributed to the reduction of TAP-mimic mechanical properties, this characteristic 
may have positively contributed to the drug release (Fig. 2). All drugs displayed an initial 
burst release within the first 24 hours, corroborating with previous findings (18), which 
demonstrated similar MET and CIP release profiles. We also investigated the release profile 
of MINO. Interestingly, MINO drug concentration was progressively reduced after 24 hours, 
with no further release after 2 weeks (Fig. 2A). One could speculate that some chemical 
reactions may have occurred between MINO and one of the compounds used in the HPLC 
analysis. Indeed, according to Tanase et al (27), MINO may ionize in the acid mobile phase 
of the system, leading to ion-pair formation and, consequently, to its retention in the solid 
phase. Future studies will investigate alternative HPLC systems to better evaluate MINO 
release. Nonetheless, the amount of drugs released from the TAP-mimic scaffold throughout 
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the study is well above (Fig. 2A) the minimum inhibitory concentration for A. naeslundii 
(eg, antibiotic within the tetracycline family such as doxycycline, minimum inhibitory 
concentration = 0.064 μg/mL) (5).
A recent study reported the detection of A. naeslundii in initial samples recovered from the 
infected root canals of necrotic immature permanent teeth that had undergone trauma 2 days 
to 8 years previously (7). Previous studies have investigated A. naeslundii associated with 
other bacteria, aiming to form multispecies biofilms (5, 28). To the best of our knowledge, 
no attempt has been made to study the influence of time on the formation of A. naeslundii 
biofilm on dentin. Here, a young, 7-day-old A. naeslundii biofilm on dentin was developed. 
Our data revealed numerous bacteria agglomerates fairly well-distributed over the entire 
dentin surface (SEM), as well as inside the dentinal tubules (CSLM) (Fig. 3A and E), 
without the need for special specimen preparation (ie, centrifugation). Importantly, several 
studies have performed dentin specimen centrifugation to permit the deep penetration of 
bacteria inside dentinal tubules, simulating long-term infection and to allow for assessment 
of the antimicrobial effects inside the dentinal tubules (21–23). One can speculate that the 
adhesion of A. naeslundii to dentin surface occurs by means of their unique surface 
structures, so-called type 1 fimbriae that help them to attach to collagen structures (29, 30).
Clinical strategies currently advocated to achieve bacteria/biofilm elimination of the root 
canal make use of potent chemical substances (eg, TAP), which can be considered extremely 
toxic to stem cells (4). During the past few years, TAP has been one of the most studied 
intracanal medicaments as a disinfection step within the regenerative approach. Nonetheless, 
recent findings have warned about the drawbacks associated with its use (ie, stem cell 
toxicity (14) and aesthetic issues (31)). Meanwhile, novel antibiotic-containing scaffolds 
(eg, TAP-mimic scaffolds) have been developed through the wise combination of 
biodegradable and compatible polymers and considerably lower antibiotic(s) concentration. 
Notably, the concentration of the 3 antibiotics used to synthesize TAP-mimic scaffolds 
generally accounts for a few milligrams of drugs (per scaffold), as opposed to the clinically 
used concentration of TAP paste (1 g/mL). Tooth discoloration has been attributed to MINO 
that acts through the chelation of calcium ions, forming an insoluble complex (27). In this 
study, dentin discoloration was seen after TAP solution and TAP-mimic scaffold treatments. 
Moreover, SEM images revealed the formation of calcium-enriched insoluble agglomerates 
over the dentin surface (27) as demonstrated by energy-dispersive x-ray spectroscopy 
analyses (Fig. 3N, inset). Studies removing or replacing MINO by Augmentin or Cefaclor as 
intracanal medications have started as potential alternatives to prevent and/or minimize tooth 
discoloration (32, 33). Indeed, from an antimicrobial viewpoint, this novel TAP-mimic 
scaffold demonstrated a significant reduction in viable biofilm, even inside dentinal tubules 
(Fig. 3C). The microbial data obtained after treating the A. naeslundii biofilm with TAP-
mimic scaffold were similar to those achieved after TAP solution, which carried a 
considerably higher concentration of antibiotics (50 mg/mL of each drug).
Previous studies have demonstrated the antimicrobial effects of both the triple and double 
antibiotic pastes against Enterococcus faecalis and Porphyromonas gingivalis biofilms (34, 
35). However, no study has investigated the antimicrobial efficacy of TAP on A. naeslundii 
dentin biofilm. In vitro research has demonstrated that Actinomyces species were resistant to 
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MET but susceptible to moxifloxacin (ie, CIP family) and amoxicillin (5). Therefore, one 
could certainly argue that both CIP and MINO present in the TAP-mimic scaffold were 
responsible for most of the antimicrobial action against A. naeslundii biofilm. Future studies 
will be designed to explore the antimicrobial effects of this novel TAP-mimic scaffold 
against other bacteria as well as a multispecies biofilm before a preclinical animal study is 
conducted. Moreover, future clinical application of this TAP-mimic scaffold must consider 
the insertion mechanism, removal, and interference with organic material including fluids 
and/or blood inside root canals.
Taken together, the novel TAP-mimic scaffolds promoted a significant reduction in A. 
naeslundii biofilm formed on human dentin. In conjunction with cell-based assays, higher 
concentrations of the 3 drugs could be proposed to amplify the antimicrobial efficacy 
without jeopardizing cell compatibility.
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Figure 1. 
SEM micrographs (original magnification, ×1500 and ×5000) of pure PDS (A) and TAP-
mimic (B) scaffolds obtained via electrospinning (processing parameters used: needle-
collector distance of 18 cm, flow rate of 2 mL.h−1, and voltage of 15–19 kV). Both scaffolds 
presented a porous structure and smooth fibers with similar average fiber diameter, although 
the former (C) showed a wider range of diameter distribution (heterogeneous) compared 
with the latter (D), which displayed a gaussian distribution (homogeneous). Regarding the 
mechanical analysis (ie, tensile strength [E], Young's modulus [F], and elongation at break 
[G]), statistically significant differences between drug-free scaffolds (pure PDS) and TAP-
mimic scaffolds were seen (represented by different uppercase [dry condition] and 
lowercase [wet condition] letters [P < .05]). In detail, under dry conditions, the TAP-mimic 
scaffold demonstrated similar tensile strength (P = .133) and elongation at break (P = .200) 
when compared with pure PDS, although presenting with a lower Young's modulus (P < .
001). After hydration, lower mechanical properties (P ≤ .040) were obtained for the TAP-
mimic scaffold when compared with the control. Asterisk (*) above bar columns indicates 
statistically significant difference between dry and wet storage conditions (P < .05).
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Figure 2. 
Mean drug release profile (A) and percentage of drug release (B) of TAP-mimic scaffold up 
to 28 days of incubation in PBS (37°C). Mean ± standard deviations of released drugs are 
presented in the inset table.
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Figure 3. 
CLSM images were collected in sequential illumination mode by using 488-nm and 552-nm 
laser lines. Fluorescent emission was collected in 2 HyD spectral detectors with filter range 
set up to 500–550 nm and 590–655 nm for green (SYTO9) and red dye (PI), respectively. 
CLSM macrophotographs of 7-day A naeslundii biofilm (negative control) growth inside 
dentinal tubules (A), infected dentin treated with pure PDS (B), TAP scaffold (C), and TAP 
solution (D) for 3 days. SEM images of A. naeslundii biofilm on the dentin surface (negative 
control) (E) treated by pure PDS (F), TAP scaffold (G), and TAP solution (H). Dentin 
discoloration images of negative control (I), pure PDS (J), TAP scaffold (K), and TAP 
solution (L) groups. Representative SEM images (original magnification, ×200 and ×1000) 
of TAP solution treated dentin showing calcium-enriched (Ca) insoluble agglomerates 
attached to the dentin surface (M) and covering dentinal tubules (N) as demonstrated by 
energy-dispersive x-ray spectroscopy (EDS) analyses (inset EDS image N); A. naeslundii 
can be seen on the surface of this insoluble complex (white arrows) (N and H).
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